THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.
EMED is pleased to announce the remaining Open Offer Shares not originally subscribed for under the Open Offer (the “Rump Placing”) have all been placed and the Capital Raising of £64.9 million is fully subscribed.
Of the 26,399,206 Open Offer Shares available in the Rump Placing, 13,057,868 have been placed with institutional investors by Canaccord Genuity and Brandon Hill (the “Bookrunners”) at a placing price of 4.75 pence per New Ordinary Share. Additionally, Mr Harry Liu, a director of the Company, has agreed today to subscribe directly with the Company for 13,341,338 New Ordinary Shares at a subscription price of 4.75 pence per New Ordinary Shares.
Accordingly, when including the additional conditional subscriptions described above all of the 71,993,297 New Ordinary Shares originally available under the Open Offer are expected to be conditionally subscribed for raising gross proceeds of £3.4 million.
Admission to trading on AIM of the 71,993,297 New Ordinary Shares to be issued pursuant to the Open Offer and Rump Placing is expected to commence at 8.00 a.m. (BST) on 24 June 2015, subject to the passing of the Resolutions at the Extraordinary General Meeting to be held today at 11.00 a.m. (BST) at the offices of Field Fisher Waterhouse LLP, 9th Floor, Riverbank House, 2 Swan Lane, London EC4R 3TT, United Kingdom. Settlement and release of proceeds to the Company of the Capital Raising is anticipated on or around the 24 June 2015, save for the settlement of the Rump Placing (which includes Mr Liu’s subscription) which is expected in a further 10 days’ time. As a result of Mr Liu’s subscription he will have a beneficial holding in the Company representing 0.4 per cent. of the Enlarged Share Capital of the Company following the completion of the Capital Raising.
Upon Admission, following completion of the Subscription, Placing, Open Offer and Capitalisation Issue, the Company’s total voting rights will total 3,500,386,633 ordinary shares of 0.25 pence each. This above figure may be used by shareholders as a denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, EMED under the Company’s Articles of Association.
Capitalised terms in this Announcement, unless otherwise defined, have the same meaning given to them in the announcement issued by the Company on 28 May 2015.
|EMED||Roger Davey/Alberto Lavandeira||+34 959 59 28 50|
|Canaccord Genuity Limited (Corporate Broking)||Henry Fitzgerald-O’Connor/Oliver Donaldson||+44 207 523 8000|
|Canaccord Genuity Limited (ECM)||Kit Stephenson||+44 207 523 8000|
|Brandon Hill Capital||Oliver Stansfield||+44 203 463 5061|
|Walbrook PR||Nick Rome||+44 207 933 8783|
No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by either of the Bookrunners or by any of their respective affiliates or agents or brokers, as to or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.
Canaccord Genuity is acting for the Company and for no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Canaccord Genuity nor for providing advice to any other person in relation to any matter referred to herein. Canaccord Genuity is authorised and regulated in the United Kingdom by the Financial Conduct Authority (“FCA”).
Brandon Hill is acting for the Company and for no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Brandon Hill nor for providing advice to any other person in relation to any matter referred to herein. Brandon Hill is authorised and regulated in the United Kingdom by the FCA.
The distribution of this announcement in certain jurisdictions may be restricted by law. No action has been taken by the Company, Canaccord Genuity or Brandon Hill that would permit the possession or distribution of this announcement in any such jurisdiction. Persons into whose possession this announcement becomes available are required by the Company, Canaccord Genuity and Brandon Hill to inform themselves about, and to observe, such restrictions.
The information in this announcement shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would require preparation of a prospectus or other offer documentation, or be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.